ID   OMC-2 Prex2a shRNA type 1
AC   CVCL_A8Q6
SY   OMC-2, Prex2a shRNA type 1; OMC-2_Prex2a_shRNA1
DR   GEO; GSM2599695
DR   GEO; GSM2599696
DR   Wikidata; Q102114683
RX   PubMed=29872505;
CC   Population: Japanese.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:22950; PREX2.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3353 ! OMC-2
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
RX   PubMed=29872505; DOI=10.18632/oncotarget.25349; PMCID=PMC5973852;
RA   Takeshita S., Yamashita Y., Shiomi K., Suzuki N., Yoshida J.,
RA   Naiki-Ito A., Suzuki S., Akatsuka S., Toyokuni S., Takahashi T.,
RA   Mase S., Arakawa A., Sugiura-Ogasawara M., Takahashi S.;
RT   "Expression of P-REX2a is associated with poor prognosis in
RT   endometrial malignancies.";
RL   Oncotarget 9:24778-24786(2018).
//